IMCR

Immunocore Holdings plc

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$30.48

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %20.3 / %30

Non-compliant assets / Total market cap %43.4 / %30

Non-compliant revenue / Total income %3.2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma.

Website

Analysis (Turkish): IMCR Hissesi Caiz mi, Helal mi? Immunocore Holdings plc Katılım Analizi